Protective Effects of Peroxiredoxin 6 in Pro-Inflammatory Response Model Using Raw 264.7 Macrophages

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Pro-inflammatory responses in macrophages are crucial in innate immunity.
• Endotoxin exposure triggers significant inflammatory cascades.
• Peroxiredoxin 6 (PRDX6) is an antioxidant protein with potential immunomodulatory roles.

Purpose of the Study:

• To investigate the effects of recombinant antioxidant protein PRDX6 on RAW 264.7 macrophage inflammatory responses to endotoxin.
• To determine PRDX6's impact on cytokine production, reactive oxygen species (ROS), and apoptosis.

Main Methods:

• RAW 264.7 macrophages were exposed to lipopolysaccharide (LPS) with and without PRDX6.
• Quantification of pro-inflammatory cytokines (TNF-α, IL-1β) and ROS production.
• Analysis of gene expression for iNos, Nrf-2, NF-κB, SAPK/JNK, and P53.
• Assessment of apoptosis markers.

Main Results:

• PRDX6 significantly decreased TNF-α production by 15-20% and normalized IL-1β levels.
• PRDX6 reduced LPS-induced ROS production and iNos gene overexpression.
• PRDX6 suppressed Nrf-2 gene expression and NRF-2 transcription factor production in early stages.
• PRDX6 inhibited NF-κB and SAPK/JNK signaling pathways activation.
• PRDX6 suppressed P53 gene expression, indicating reduced apoptosis.

Conclusions:

• Recombinant PRDX6 exhibits potent anti-inflammatory effects on macrophages stimulated by endotoxin.
• PRDX6 mitigates key inflammatory mediators, ROS production, and apoptosis.
• PRDX6 demonstrates a protective role against endotoxin-induced cellular damage and inflammation.